Legal Articles

Since the early 1970s, Dr. Peter Breggin has been active as a medical expert in malpractice and product liability suits, as well as criminal cases in which psychiatric or psychoactive drugs have contributed to abnormal behavior. He has also testified in cases involving involuntary treatment, electroshock treatment, and psychosurgery. He has testified more than 70 times in court.

In the 1990s, Dr. Breggin was chosen to be the medical and scientific expert for nearly 200 combined Prozac product liability suits against Eli Lilly and Company. This resulted in his testifying in the infamous Wesbecker case in which the manufacturer, Eli Lilly, fixed the trial. Link. Later Dr. Breggin would become an expert in many other product liability suits involving antidepressants, stimulants, tranquilizers and antipsychotic drugs, nearly all of which were settled. As an expert in these product liability suits, the courts have empowered Dr. Breggin to examine secret company records concerning the development and marketing of their drugs. This unique experience of looking inside otherwise hidden drug company files has provided him a unique source of information and a special understanding of drug company activities that he has used in his legal work and documented in many publications, including Brain-Disabling Treatments in Psychiatry (2008) and Medication Madness (2008).

Among his proudest achievements, in the early 1970s Dr. Breggin was the medical expert in the famous Kaimowitz case that stopped lobotomy and psychosurgery in America’s state mental hospitals. LINK More recently he was the psychiatric expert in a psychosurgery case against the Cleveland Clinic that resulted in a huge verdict for the injured woman and caused the clinic to stop doing any further psychosurgery. LINK Dr. Breggin was also the medical expert in the only electroshock malpractice suit to be won by the plaintiffs. LINK.

Some of Dr. Breggin’s most successful legal work has involved testimony in tardive dyskinesia malpractice suits involving this usually irreversible abnormal movement disorder commonly caused by antipsychotic or neuroleptic drugs. In all but one of the many TD trials in which he has participated in the United States and Canada, the injured patient has won a favorable verdict. The one exception ended in a hung jury. He has also been involved in tardive dyskinesia cases with multi-million dollar settlements without going to trial in both the United States and Canada.

Dr. Breggin continues with both his clinical practice and his medical expert work.

$700,000 Tardive Dyskinesia Settlement

  Dr. Peter Breggin was the medical expert in a tardive dyskinesia (TD) case that settled out of court for $700,000 in May 2014. The identity of the doctor and the plaintiff cannot be released. Large medical malpractice settlements are extremely rare in the locality of the case. Dr. Breggin has been an expert in […]

Read More

$1.5 Million Award in Child Tardive Dyskinesia Malpractice Dr. Peter Breggin Testified as the Psychiatric Expert

February 11, 2014   On February 11, 2014 a Chicago jury awarded $1.5 million to an autistic child who developed a severe case of tardive dyskinesia and tardive akathisia while being treated by psychiatrists with Risperdal and then Zyprexa between 2002 and 2007. The drug-induced disorder was diagnosed when he was fifteen years old and […]

Read More

More reasons not to take psychiatric drugs

It’s now well known that the newer antidepressants like Prozac, Paxil, Zoloft and Celexa cause suicidal thoughts and behavior, and can worsen depression. Psychiatric drugs sustained another blow when the FDA recently declared that yet another group of these chemical agents causes the very problems that the drugs are supposed to treat. This time the […]

Read More

Antidepressant-induced suicidality and violence: more about deception than science

Report Presented at the September 14, 2004 Press Conference Sponsored by the Alliance for Human Research Protection (AHRP) at the FDA Public Hearing on Antidepressants and Suicide. Antidepressant-Induced Suicidality and Violence: More About Deception than Science Observations Made at the FDA Hearings Press Conference, September 14, 2004 By Peter R. Breggin, M.D. The FDA is […]

Read More

The Proven Dangers of Antidepressants

by Peter R. Breggin, M.D. On March 22 the FDA issued an extraordinary “Public Health Advisory” that cautioned about the risks associated with the whole new generation of antidepressants including Prozac and its knock offs, Zoloft, Paxil, Luvox, Celexa, and Lexapro, as well as Wellbutrin, Effexor, Serzone, and Remeron. The warning followed a public hearing […]

Read More

FDA Issues Public Health Advisory on Cautions for Use of Antidepressants in Adults and Children   The Food and Drug Administration today issued a Public Health Advisory that provides further cautions to physicians, their patients, and families and caregivers of patients about the need to closely monitor both adults and children with depression, especially at […]

Read More

The FDA Continues to Affirm Antidepressant Risks First Identified in my 1991 Book Toxic Psychiatry By Peter R. Breggin, M.D. Ithaca, New York   In 2004 the FDA issued a black box warning about the increased risk of suicidality in children taking the newer antidepressants, including the SSRIs (Prozac, Zoloft, Paxil, Luvox, Celexa, and […]

Read More